Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells

Molecular and Cellular Proteomics

Volumn 11, Issue 4, 2012, Pages

  Chen, G Yi ^a   Chi, Lang Ming ^a   Chi, Hsiang Cheng ^a   Tsai, Ming Ming ^a,b   Tsai, Chung Ying ^a   Tseng, Yi Hsin ^a   Lin, Yang Hsiang ^a   Chen, Wei Jan ^c   Huang, Ya Hui ^c   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN SPECIFIC SERINE PROTEASE 4; LIOTHYRONINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE; UNCLASSIFIED DRUG; UROKINASE; AMINO ACID; PROTEOME; SERPINE1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEOMICS; RAT; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER INVASION; CELL MOTION; GENETICS; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TUMOR VOLUME;

AMINO ACIDS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATOGRAPHY, LIQUID; HUMANS; ISOTOPE LABELING; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY; TRIIODOTHYRONINE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84859807729     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.011270     Document Type: Article

References (77)

1. Cheng, S. Y. (2000) Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev. Endocr. Metab. Disord. 1, 9-18
2. Aranda, A., and Pascual, A. (2001) Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269-1304 (Pubitemid 32606670)
3. Larsen, P. R. (2009) Thyroid hormone analogs and metabolites: new applications for an old hormone? Nat. Clin. Pract. Endocrinol. Metab. 5, 1
4. Beato, M., Herrlich, P., and Schütz, G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857 (Pubitemid 26006527)
5. Lazar, M. A. (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14, 184-193
6. Yen, P. M., and Chin, W. W. (1994) New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol. Metab. 5, 65-72 (Pubitemid 24145851)
7. Perlmann, T., Rangarajan, P. N., Umesono, K., and Evans, R. M. (1993) Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7, 1411-1422 (Pubitemid 23210889)
8. Yen, P. M., Ikeda, M., Wilcox, E. C., Brubaker, J. H., Spanjaard, R. A., Sugawara, A., and Chin, W. W. (1994) Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity. J. Biol. Chem. 269, 12704-12709 (Pubitemid 24202062)
9. Yen, P. M. (2001) Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-1142
10. Wood, W. M., Dowding, J. M., Bright, T. M., McDermott, M. T., Haugen, B. R., Gordon, D. F., and Ridgway, E. C. (1996) Thyroid hormone receptor beta2 promoter activity in pituitary cells is regulated by Pit-1. J. Biol. Chem. 271, 24213-24220
11. Chamba, A., Neuberger, J., Strain, A., Hopkins, J., Sheppard, M. C., and Franklyn, J. A. (1996) Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J. Clin. Endocrinol. Metab. 81, 360-367 (Pubitemid 26035046)
12. Lin, K. H., Chen, C. Y., Chen, S. L., Yen, C. C., Huang, Y. H., Shih, C. H., Shen, J. J., Yang, R. C., and Wang, C. S. (2004) Regulation of fibronectin by thyroid hormone receptors. J. Mol. Endocrinol. 33, 445-458
13. Lin, K. H., Lee, H. Y., Shih, C. H., Yen, C. C., Chen, S. L., Yang, R. C., and Wang, C. S. (2003) Plasma protein regulation by thyroid hormone. J. Endocrinol. 179, 367-377
14. Tai, P. J., Huang, Y. H., Shih, C. H., Chen, R. N., Chen, C. D., Chen, W. J., Wang, C. S., and Lin, K. H. (2007) Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors. Endocrinology 148, 3485-3495
15. Lin, K. H., Shieh, H. Y., and Hsu, H. C. (2000) Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 141, 2540-2547
16. Chen, R. N., Huang, Y. H., Lin, Y. C., Yeh, C. T., Liang, Y., Chen, S. L., and Lin, K. H. (2008) Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology 149, 3817-3831
17. Chen, R. N., Huang, Y. H., Yeh, C. T., Liao, C. H., and Lin, K. H. (2008) Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Res. 68, 1697-1706
18. Mohamed, M. M., and Sloane, B. F. (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775 (Pubitemid 44450465)
19. Wilson, T. J., and Singh, R. K. (2008) Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochim. Biophys. Acta 1785, 85-95
20. Hofmann, U. B., Eggert, A. A., Blass, K., Bröcker, E. B., and Becker, J. C. (2003) Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res. 63, 8221-8225 (Pubitemid 37549471)
21. Piersma, S. R., Fiedler, U., Span, S., Lingnau, A., Pham, T. V., Hoffmann, S., Kubbutat, M. H., and Jiménez, C. R. (2010) Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J. Proteome Res. 9, 1913-1922
22. Planque, C., Kulasingam, V., Smith, C. R., Reckamp, K., Goodglick, L., and Diamandis, E. P. (2009) Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol. Cell. Proteomics 8, 2746-2758
23. Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A., and Pandey, A. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 5, 157-171 (Pubitemid 43169348)
24. Chenau, J., Michelland, S., de Fraipont, F., Josserand, V., Coll, J. L., Favrot, M. C., and Seve, M. (2009) The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells. J. Proteome Res. 8, 4579-4591
25. Mathias, R. A., Wang, B., Ji, H., Kapp, E. A., Moritz, R. L., Zhu, H. J., and Simpson, R. J. (2009) Secretome-based proteomic profiling of Rastransformed MDCK cells reveals extracellular modulators of epithelialmesenchymal transition. J. Proteome Res. 8, 2827-2837
26. Dass, K., Ahmad, A., Azmi, A., Sarkar, S., and Sarkar, F. (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Rev. 34, 122-136
27. Samuels, H. H., Stanley, F., and Casanova, J. (1979) Depletion of L-3,5,3′- triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105, 80-85 (Pubitemid 9199127)
28. Ong, S. E., and Mann, M. (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 1, 2650-2660
29. Wu, C. C., Chen, H. C., Chen, S. J., Liu, H. P., Hsieh, Y. Y., Yu, C. J., Tang, R., Hsieh, L. L., Yu, J. S., and Chang, Y. S. (2008) Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 8, 316-332 (Pubitemid 351212330)
30. Li, Y., Yu, J., Wang, Y., Griffin, N. M., Long, F., Shore, S., Oh, P., and Schnitzer, J. E. (2009) Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol. Cell. Proteomics 8, 1219-1235
31. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9, 1100-1117
32. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
33. Cox, J., Matic, I., Hilger, M., Nagaraj, N., Selbach, M., Olsen, J. V., and Mann, M. (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4, 698-705
34. Bendtsen, J. D., Nielsen, H., von Heijne, G., and Brunak, S. (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783-795 (Pubitemid 38829638)
35. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G., and Brunak, S. (2004) Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356 (Pubitemid 39093515)
36. Möller, S., Croning, M. D., and Apweiler, R. (2001) Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17, 646-653 (Pubitemid 32707587)
37. Liao, C. H., Yeh, S. C., Huang, Y. H., Chen, R. N., Tsai, M. M., Chen, W. J., Chi, H. C., Tai, P. J., Liao, C. J., Wu, S. M., Cheng, W. L., Pai, L. M., and Lin, K. H. (2010) Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion. Endocrine Related Cancer 17, 99-111
38. Wu, S. M., Huang, Y. H., Lu, Y. H., Chien, L. F., Yeh, C. T., Tsai, M. M., Liao, C. H., Chen, W. J., Liao, C. J., Cheng, W. L., and Lin, K. H. (2010) Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines. Cell. Mol. Life Sci. 67, 1831-1843
39. Huang, Y. H., Lee, C. Y., Tai, P. J., Yen, C. C., Liao, C. Y., Chen, W. J., Liao, C. J., Cheng, W. L., Chen, R. N., Wu, S. M., Wang, C. S., and Lin, K. H. (2006) Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones. Endocrinology 147, 2481-2489
40. Repesh, L. A. (1989) A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9, 192-208
41. Shih, C. H., Chen, S. L., Yen, C. C., Huang, Y. H., Chen, C. D., Lee, Y. S., and Lin, K. H. (2004) Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145, 2804-2814
42. Martínez-Iglesias, O., Garcia-Silva, S., Regadera, J., and Aranda, A. (2009) Hypothyroidism enhances tumor invasiveness and metastasis development. PLoS One 4, e6428
43. Kowalik, M. A., Perra, A., Pibiri, M., Cocco, M. T., Samarut, J., Plateroti, M., Ledda-Columbano, G. M., and Columbano, A. (2010) TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells. J. Hepatol. 53, 686-692
44. Benvenga, S., Cahnmann, H. J., Rader, D., Kindt, M., Facchiano, A., and Robbins, J. (1994) Thyroid hormone binding to isolated human apolipoproteins A-II, C-I, C-II, and C-III: homology in thyroxine binding sites. Thyroid 4, 261-267 (Pubitemid 24295420)
45. Lin-Lee, Y. C., Strobl, W., Soyal, S., Radosavljevic, M., Song, M., Gotto, A. M., Jr., and Patsch, W. (1993) Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver. J. Lipid Res. 34, 249-259 (Pubitemid 23067530)
46. Prieur, X., Huby, T., Coste, H., Schaap, F. G., Chapman, M. J., and Rodríguez, J. C. (2005) Thyroid hormone regulates the hypotriglyceridemic gene APOA5. J. Biol. Chem. 280, 27533-27543 (Pubitemid 41076864)
47. Kardassis, D., Roussou, A., Papakosta, P., Boulias, K., Talianidis, I., and Zannis, V. I. (2003) Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids. Biochem. J. 372, 291-304 (Pubitemid 36723875)
48. Lambrinoudaki, I., Kaparos, G., Rizos, D., Galapi, F., Alexandrou, A., Sergentanis, T. N., Creatsa, M., Christodoulakos, G., Kouskouni, E., and Botsis, D. (2009) Apolipoprotein E and paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women. Clin. Endocrinol. 71, 284-290
49. Izaguirre, M. F., and Casco, V. H. (2010) T3 regulates E-cadherin, and betaand alpha-catenin expression in the stomach during the metamorphosis of the toad Rhinella arenarum. Biotech. Histochem. 85, 305-323
50. Rigaud, D., Tallonneau, I., and Vergè s, B. (2009) Hypercholesterolaemia in anorexia nervosa: frequency and changes during refeeding. Diabetes Metab. 35, 57-63
51. Varga, F., Rumpler, M., Zoehrer, R., Turecek, C., Spitzer, S., Thaler, R., Paschalis, E. P., and Klaushofer, K. (2010) T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem. Biophys. Res. Commun. 402, 180-185
52. Haas, M. J., Mreyoud, A., Fishman, M., and Mooradian, A. D. (2004) Microarray analysis of thyroid hormone-induced changes in mRNA expression in the adult rat brain. Neurosci. Lett. 365, 14-18 (Pubitemid 38952726)
53. Cakal, B., Cakal, E., Demirbas, B., Ozkaya, M., Karaahmetoǧlu, S., Serter, R., and Aral, Y. (2007) Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients. J. Korean Med. Sci. 22, 431-435
54. Ventura-Holman, T., Mamoon, A., Subauste, M. C., and Subauste, J. S. (2011) The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma. Mol. Biol. Rep. 38, 1137-1144
55. Zhao, L. N., Xu, J., Peng, X. L., Tian, L. Y., Hao, L. P., Yang, X. F., Ying, C. J., and Sun, X. F. (2010) Dose and time-dependent hypercholesterolemic effects of iodine excess via TRbeta1-mediated down regulation of hepatic LDLr gene expression. Eur. J. Nutr. 49, 257-265
56. Erem, C., Ersoz, H. O., Karti, S. S., Ukinc, K., Hacihasanoglu, A., Deǧer, O., and Telatar, M. (2002) Blood coagulation and fibrinolysis in patients with hyperthyroidism. J. Endocrinol. Invest. 25, 345-350 (Pubitemid 34436130)
57. Erem, C., Ucuncu, O., Yilmaz, M., Kocak, M., Nuhoglu, I., and Ersoz, H. O. (2009) Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 35, 75-80
58. Beazley, K. E., Canner, J. P., and Linsenmayer, T. F. (2009) Developmental regulation of the nuclear ferritoid-ferritin complex of avian corneal epithelial cells: roles of systemic factors and thyroxine. Exp. Eye Res. 89, 854-862
59. Biz, C., Oliveira, C., Mattos, A. B., Oliveira, J., Ribeiro, E. B., Oller do Nascimento, C. M., and Oyama, L. M. (2009) The effect of thyroid hormones on the white adipose tissue gene expression of PAI-1 and its serum concentration. Braz. J. Med. Biol. Res. 42, 1163-1166
60. Nikolsky, Y., Ekins, S., Nikolskaya, T., and Bugrim, A. (2005) A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158, 20-29 (Pubitemid 40910724)
61. Wu, S. M., Huang, Y. H., Yeh, C. T., Tsai, M. M., Liao, C. H., Cheng, W. L., Chen, W. J., and Lin, K. H. (2011) Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene
62. Gomis-Rüth, F. X. (2003) Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 24, 157-202
63. Yasuda, S., Morokawa, N., Wong, G. W., Rossi, A., Madhusudhan, M. S., Sali, A., Askew, Y. S., Adachi, R., Silverman, G. A., Krilis, S. A., and Stevens, R. L. (2005) Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/ PRSS22. Blood 105, 3893-3901 (Pubitemid 40656134)
64. Chan, I. H., and Privalsky, M. L. (2009) Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene 28, 4162-4174
65. del Re, E. C., Shuja, S., Cai, J., and Murnane, M. J. (2000) Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br. J. Cancer 82, 1317-1326 (Pubitemid 30145352)
66. Sivaparvathi, M., Sawaya, R., Gokaslan, Z. L., Chintala, S. K., Rao, J. S., and Chintala, K. S. (1996) Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett. 104, 121-126 (Pubitemid 26154022)
67. Kos, J., Stabuc, B., Schweiger, A., Krasovec, M., Cimerman, N., Kopitar- Jerala, N., and Vrhovec, I. (1997) Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3, 1815-1822 (Pubitemid 27444722)
68. Gabrijelcic, D., Svetic, B., Spaić, D., Skrk, J., Budihna, M., Dolenc, I., Popovic, T., Cotic, V., and Turk, V. (1992) Cathepsins B, H and L in human breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 69-74
69. Liao, C. J., Wu, T. I., Huang, Y. H., Chang, T. C., Wang, C. S., Tsai, M. M., Hsu, C. Y., Tsai, M. H., Lai, C. H., and Lin, K. H. (2011) Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol. Oncol. 120, 135-144
70. Webb, D. J., Thomas, K. S., and Gonias, S. L. (2001) Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth. J. Cell Biol. 152, 741-752
71. Romer, M. U., Larsen, L., Offenberg, H., Brünner, N., and Lademann, U. A. (2008) Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway. Neoplasia 10, 1083-1091
72. Bajou, K., Peng, H., Laug, W. E., Maillard, C., Noel, A., Foidart, J. M., Martial, J. A., and DeClerck, Y. A. (2008) Plasminogen activator inhibitor- 1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14, 324-334
73. Slany, A., Haudek, V. J., Zwickl, H., Gundacker, N. C., Grusch, M., Weiss, T. S., Seir, K., Rodgarkia-Dara, C., Hellerbrand, C., and Gerner, C. (2010) Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J. Proteome Res. 9, 6-21
74. Waltz, D. A., Natkin, L. R., Fujita, R. M., Wei, Y., and Chapman, H. A. (1997) Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100, 58-67 (Pubitemid 27311243)
75. Collen, D. (1999) The plasminogen (fibrinolytic) system. Thromb. Haemost. 82, 259-270
76. Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A., and Stacey, S. N. (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68, 1-19 (Pubitemid 20015463)
77. Lin, K. H., Lin, Y. W., Lee, H. F., Liu, W. L., Chen, S. T., Chang, K. S., and Cheng, S. Y. (1995) Increased invasive activity of human hepatocellular carcinoma cells is associated with an overexpression of thyroid hormone beta 1 nuclear receptor and low expression of the anti-metastatic nm23 gene. Cancer Lett. 98, 89-95